Du Xinyu
Known title: Sr. VP, Global R&DCIK: 0002051551
Associated companies
Transaction History
| FUL | ▲ Buy | Option Exercise | 448 | $27K | 1/27/2026 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 134 | $8K | 1/27/2026 | View on chart |
| FUL | ▲ Buy | Option Exercise | 199 | $12K | 1/26/2026 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 61 | $4K | 1/26/2026 | View on chart |
| FUL | ▲ Buy | Grant | 5 | $300 | 1/24/2026 | View on chart |
| FUL | ▲ Buy | Option Exercise | 374 | $22K | 1/24/2026 | View on chart |
| FUL | ▲ Buy | Option Exercise | 162 | $10K | 1/24/2026 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 50 | $3K | 1/24/2026 | View on chart |
| FUL | ▼ Sell | Tax Withholding | 116 | $7K | 1/24/2026 | View on chart |
| FUL | ▼ Sell | Open Market | 69 | $4K | 1/28/2025 | View on chart |
| FUL | ▼ Sell | Open Market | 240 | $15K | 1/27/2025 | View on chart |
| FUL | ▲ Buy | Option Exercise | 197 | $12K | 1/26/2025 | View on chart |
| FUL | ▲ Buy | Option Exercise | 127 | $8K | 1/24/2025 | View on chart |
| FUL | ▲ Buy | Option Exercise | 408 | $25K | 1/24/2025 | View on chart |
| FUL | ▲ Buy | Option Exercise | 155 | $10K | 1/24/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
H.B. Fuller prices $850 million senior notes offering
H.B. Fuller has priced an $850 million senior notes offering, a move that adds to the company's debt load. The stock is currently trading near the lower end of its 52-week range, with an RSI of 41.5 indicating moderate weakness. This capital raise provides context for investors monitoring the company's financial structure alongside its recent price action.
H.B. Fuller prices $850 million senior notes offering. H.B. Fuller has priced an $850 million senior notes offering, a move that adds to the company's debt load. The stock is currently trading near the lower end of its 52-week range, with an RSI of 41.5 indicating moderate weakness. This capital raise provides context for investors monitoring the company's financial structure alongside its recent price action.